Trial Profile
Repeated administration of DSP-5423P in patients with Schizophrenia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Blonanserin (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Sumitomo Dainippon Pharma
- 17 Nov 2014 New trial record